-
Burden of Illness Among Patients With Transfusion Dependent Beta-Thalassemia in Spain: A Registry-Based Study
Sep 9, 2025, 16:22 PM -
Why Current HTA Frameworks Fall Short for Anti-Cancer Combination Therapies: Toward Equitable Value Attribution and Policy Reform
Sep 9, 2025, 16:22 PM -
A Decade in Decision Making: Reviewing Trends in STAS by NICE in Different Disease Areas
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Second-Generation Colon Capsule Endoscopy for Investigation of the Colon Through Direct Visualization
Sep 9, 2025, 16:22 PM -
ShinyMMD: An Open-Source Shiny Web Application for a Computer Simulation Model for Type 2 Diabetes and Its Complications
Sep 9, 2025, 16:22 PM -
Costs Associated With the Administration, Postinfusion Monitoring, and Management of Adverse Events (AEs) Related to Novel Drugs for Second-Line (2L+) Treatment of Small-Cell Lung Cancer (SCLC)
Sep 9, 2025, 16:22 PM -
Development of an LLM-Based Computable Phenotype for Pediatric Lymphoma Subtypes Using Structured and Unstructured Electronic Medical Record Data
Sep 9, 2025, 16:22 PM -
Assessing the Feasibility of the Implementation of a Subscription Model Pricing Solution Aimed at Broadening Access to All Eligible Patients Within the HER2 Indication
Sep 9, 2025, 16:22 PM -
Do Public Preferences Matter? Health-Economic Evaluation of Antineoplastic Medication Considering EQ-5D Value Sets From Several Countries
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of a Digital Health Intervention for Screening and Managing Hypertension at Primary Care Level in Kenya: A Microsimulation Model
Sep 9, 2025, 16:22 PM -
Surrogate Outcome Validation Within the New EU HTA Guidance Framework: Practical Considerations From an Industry Perspective Based on Experience From HTA Germany
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Adult Vaccination Programs and HTA of Vaccines Approaches in the US, UK, and France: Lessons for Poland
Sep 9, 2025, 16:22 PM -
Humanistic and Economic Burden of Primary Biliary Cholangitis: A Systematic Review of Health-Related Quality of Life Healthcare Resource Utilization and Associated Cost
Sep 9, 2025, 16:22 PM -
Resistance-Driven Treatment Failure: A Challenge to HCV Elimination in Pakistan
Sep 9, 2025, 16:22 PM -
Societal and Economic Impact of NOAC Therapy for Deep Vein Thrombosis and Pulmonary Embolism in Bulgaria
Sep 9, 2025, 16:22 PM -
Launches of Oncology Products in LATAM vs. the United States
Sep 9, 2025, 16:22 PM -
Turning the Tables: AI Halves Table Extraction Time in HEOR Systematic Reviews
Sep 9, 2025, 16:22 PM -
The Relevance of Core Outcome Sets to Improving Healthcare Decision Making
Sep 9, 2025, 16:22 PM -
Association Between Nonvalvular Atrial Fibrillation Type and Therapeutic Failure in Hospitalized Patients With History of Atrial Fibrillation Admitted to a Stepdown Unit
Sep 9, 2025, 16:22 PM -
Can Switching From Intravenous (IV) to Subcutaneous (SC) Formulations Save Time and Resources? A Service Impact Model (SIM)
Sep 9, 2025, 16:22 PM
